Impact of recent intravenous chemotherapy on outcome in severe sepsis and septic shock patients with hematological malignancies
- 24 January 2008
- journal article
- research article
- Published by Springer Nature in Intensive Care Medicine
- Vol. 34 (5), 847-855
- https://doi.org/10.1007/s00134-008-1002-2
Abstract
To compare the characteristics and outcome of patients with hematological malignancies referred to the ICU with severe sepsis and septic shock who had or had not received recent intravenous chemotherapy, defined as within 3 weeks prior to ICU admission.Keywords
This publication has 41 references indexed in Scilit:
- Intensive care in patients with newly diagnosed malignancies and a need for cancer chemotherapy*Critical Care Medicine, 2005
- Characteristics and outcomes of cancer patients requiring mechanical ventilatory support for >24 hrs*Critical Care Medicine, 2005
- Outcome in Noninvasively and Invasively Ventilated Hematologic Patients With Acute Respiratory FailureChest, 2004
- Cancer patients with septic shock: mortality predictors and neutropeniaSupportive Care in Cancer, 2004
- Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shockIntensive Care Medicine, 2004
- Simultaneous onset of acute inflammatory response, sepsis‐like symptoms and intestinal mucosal injury after cancer chemotherapyInternational Journal of Cancer, 2003
- Consider saying yes *Critical Care Medicine, 2003
- Caspofungin in Combination with Itraconazole for the Treatment of Invasive Aspergillosis in HumansClinical Infectious Diseases, 2002
- 2002 Guidelines for the Use of Antimicrobial Agents in Neutropenic Patients with CancerClinical Infectious Diseases, 2002
- The central role of the propensity score in observational studies for causal effectsBiometrika, 1983